CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 1,315 enrolled
Drug / intervention
clindamycin / benzoyl peroxide gel +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00776919
NCT00776919Phase 3Completed

A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of A Clindamycin / Benzoyl Peroxide Gel Versus Clindamycin Gel Versus Benzoyl Peroxide Gel Versus Vehicle Gel In Subjects With Acne Vulgaris

Stiefel, a GSK Company·interventional·Posted Oct 22, 2008·Updated Nov 23, 2016

In Brief

A Phase 3 clinical trial evaluating clindamycin / benzoyl peroxide gel, clindamycin gel, and 2 other interventions for Acne Vulgaris. Completed, enrolled 1,315 participants across 24 sites in 3 countries.

Detailed Summary

This is a Randomized, Double-Blind, Controlled Study to evaluate the Safety and Efficacy of a clindamycin / benzoyl peroxide gel in Subjects with Acne Vulgaris

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesBelize, Canada, United States

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 22, 2008
Enrollment StartOct 1, 2008
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 17.7 years ago

Interventions

clindamycin / benzoyl peroxide geldrug

Once a day application to the face

clindamycin geldrug

Once a day application to the face

BPO geldrug

Once a day application to the face

vehicle geldrug

Once a day application to the face